Arkolith/Insider Trading/PMVP/Form 4

Mack David Henry

President and CEO, DirectorPMV Pharmaceuticals, Inc. (PMVP) · full profile →Form 4 · filed Jan 22, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 3, 2025Option exercise(M)18K$0.53$9K552K
Dec 3, 2024Option exercise(M)92K$0.53$49K534K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 3, 2025Option exercise(M)18K—$00
Dec 3, 2024Option exercise(M)92K—$018K

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-25-001853) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for PMV Pharmaceuticals, Inc.

Build

Ask your agent about PMVP insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001415889-25-001853"
Ask your agent
Use Arkolith to summarize insider buying and selling at PMV Pharmaceuticals, Inc.
over the last 90 days and cite the filings.